Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Set To Compete With Abbott/St Jude In VADs After Buying HeartWare

This article was originally published in Clinica

Executive Summary

HeartWare has found a way to pay for the expanded commercialization of its HVAD ventricular assist device and the development of its MVAD miniaturized ventricular assist device; the Boston-area VAD-maker has agreed be acquired by medtech giant Medtronic for $1.1bn in cash.

Advertisement

Related Content

US FDA Approves Medtronic's HVAD For Destination Therapy
US Approvals Analysis: Abbott Leads Another Strong Month For Novel Approvals
Clinical Data Double-Boost Supports Medtronic's HeartWare Investment
Medtechs At The Wheel In New Health Care Landscape
Device/Diagnostics Quarterly Deal Statistics, Q2 2016

Topics

Advertisement
UsernamePublicRestriction

Register

MT103544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel